Viatris Inc (VTRS) Stock Price Today
Aura AI Summary
Key Stats
- $18.94BMarket Cap
- -Volume
- HealthSector
- $17.3952W High
- $8.7452W Low
- -Typical Hold Time
- $31.15BEnterprise Value
- 2.95%Div Yield
- -Trading Activity
Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $8.74 and a high of $17.39, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Viatris Inc
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Most Recent News
Quadient named Leader in 2026 SPARK Matrix for transforming customer communications with AI and flexibility
Quadient has been recognized as a Leader in the 2026 SPARK Matrix for Customer Communications Management by QKS Group for the sixth consecutive year. The report highlights Quadient's strength in evolving CCM from traditional document production to an...
Quadient named Leader in 2026 SPARK Matrix for customer communications management for 6th year
Quadient has been recognized as a Leader in the 2026 SPARK Matrix for Customer Communications Management (CCM) by QKS Group for the sixth consecutive year. This highlights Quadient's strength in transforming traditional document production into an AI...
Disposable endoscopes market to reach $10.47B by 2035, driven by infection control and minimally invasive procedures.
The global disposable endoscopes market, valued at $2.58 billion in 2025, is projected to grow to $10.47 billion by 2035 with a CAGR of 15.04%. Growth is fueled by rising demand for single-use endoscopes, infection prevention efforts, and increased u...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.